Nia Fogelman, PhD
Associate Research Scientist in PsychiatryCards
About
Research
Publications
2026
Mindfulness Intervention for Parent Stress and Childhood Obesity Risk: A Randomized Trial.
Fogelman N, Bernstein H, Bautista T, Savoye M, Chaplin T, Silverman W, Jastreboff A, Sinha R. Mindfulness Intervention for Parent Stress and Childhood Obesity Risk: A Randomized Trial. 2026, 157 PMID: 41786283, PMCID: PMC12989181, DOI: 10.1542/peds.2025-072230.Peer-Reviewed Original ResearchChildhood obesity riskEarly childhood obesity riskChildren's food intakeHealthy food intakeObesity riskParenting stressChild BMI z-scoreSignificant time main effectPositive parentingTime main effectsBMI z-scoreWeekly group interventionFood intakeAssessment of long-term effectsRandomized Controlled TrialsPhysical activityChild BMIGroup interventionHealthy nutritionSecondary outcomesMindfulness interventionEarly childhood risksCoprimary outcomesChildhood riskInterventionAssociations Among Stressful Events, Social Support, and Alcohol Use in Women and Men
Hovnanyan A, Sinha R, Fogelman N. Associations Among Stressful Events, Social Support, and Alcohol Use in Women and Men. Behavioral Sciences 2026, 16: 261. PMID: 41750070, PMCID: PMC12938169, DOI: 10.3390/bs16020261.Peer-Reviewed Original ResearchAlcohol Use Disorders Identification TestAlcohol Use Disorders Identification Test scoresAlcohol use severityStressful eventsSocial supportAlcohol useImpact alcohol useStressful life eventsRisk of alcohol misuseDisorders Identification TestAmount of alcohol consumptionLonger stress durationsLife eventsAlcohol riskRecent stressAlcohol misuseIdentification TestSS scoresSocial interactionAlcohol consumptionAlcohol intakeStress durationAlcoholStressorsAdult womenSafety, tolerability, and drug-drug interactions of NYX-783 and oxycodone in persons using opioids recreationally: Preliminary results from a randomized, double-blind, placebo-controlled phase 1 study
Harvanek Z, Mignosa M, Kitaneh R, Oliva H, Borelli A, Dauginikas E, Fogelman N, Sakmar E, Taylor J, DiLeone R, Sinha R, Angarita G. Safety, tolerability, and drug-drug interactions of NYX-783 and oxycodone in persons using opioids recreationally: Preliminary results from a randomized, double-blind, placebo-controlled phase 1 study. Drug And Alcohol Dependence 2026, 279: 113041. PMID: 41604752, PMCID: PMC12924154, DOI: 10.1016/j.drugalcdep.2026.113041.Peer-Reviewed Original ResearchConceptsDrug-drug interactionsOpioid use disorderDouble-blindAdverse eventsDrug effectsSubjective drug effectsPlacebo-controlled phase 1 studyPositive allosteric modulatorsPhase 1 studyDiastolic blood pressureUse disorderOxycodone dosePrimary endpointInpatient studyOpioid useSynaptic plasticityPlasma levelsContext of opioid useOxycodoneAllosteric modulatorsPupillary dilationBlood pressureNovel treatmentRespiratory safetyHealthy humans
2025
Assessing Autonomic Regulation Under Stress with the Yale Pain Stress Test in Social Drinking and Alcohol Use Disorder
Barreto S, McGowan C, Fogelman N, Sinha R, Wemm S. Assessing Autonomic Regulation Under Stress with the Yale Pain Stress Test in Social Drinking and Alcohol Use Disorder. Behavioral Sciences 2025, 15: 1732. PMID: 41464075, PMCID: PMC12729474, DOI: 10.3390/bs15121732.Peer-Reviewed Original ResearchAlcohol use disorderUse disorderSocial drinkingSocial drinking controlsHeart rate variability recoveryPredictor of chronic illnessPre-stress baselineCold pressor testDSM-5 criteriaHeart rate variabilitySubstance use disordersEffects of stressAcute stress responseDSM-5New Haven areaAutonomic reactivityDrinking controlsAutonomic flexibilityStress exposureLevels of stressStress-related chronic diseasesChronic illnessTime-period effectsClinical careRepeated trialsDevelopment of the Yale pain stress test to elicit a multi-level stress response and assess stress adaptability
Fogelman N, Barreto S, McGowan C, Wemm S, Sinha R. Development of the Yale pain stress test to elicit a multi-level stress response and assess stress adaptability. Psychopharmacology 2025, 1-14. PMID: 41361589, DOI: 10.1007/s00213-025-06972-y.Peer-Reviewed Original ResearchCold pressor taskPredictor of chronic illnessPain tolerancePre-stress baselineAcute physiological stress responseStress-related illnessesAcute stress responseLevels of stressPain stressStress responseResilient copingWithin-subject experimentPhysiological stress responseHealthy copingBasal anxietyChronic illnessSubjective distressHigher DBPHigher SBPSubjective stressGreater reactivityLower painStress testPain ratingsComponents of resilience1771-P: Influence of Stressful and Traumatic Life Events and Chronic Stress on Ad-lib Sweet Food Intake and Its Relationship to Obesity
DOYLE E, FOGELMAN N, JOSEPH K, HU P, JASTREBOFF A, SINHA R. 1771-P: Influence of Stressful and Traumatic Life Events and Chronic Stress on Ad-lib Sweet Food Intake and Its Relationship to Obesity. Diabetes 2025, 74 DOI: 10.2337/db25-1771-p.Peer-Reviewed Original ResearchTraumatic life eventsCumulative Adversity InterviewLife eventsChronic stressSweet food intakeCue contextLife traumaAcute stressCumulative stressful life eventsScript-driven imageryFood ad libitumRecent life eventsStressful life eventsTotal life eventsSnack foods ad libitumSweet food consumptionFood intakeEffects of stressChronic stress scoresStress scoresFood cuesCommunity adultsNeutral contextsCue conditionTraumatic eventsPregnenolone reduces provoked craving and cocaine use in men and women with cocaine use disorder: A pilot trial
Sakmar E, Wemm S, Fogelman N, Hermes G, Sinha R, Milivojevic V. Pregnenolone reduces provoked craving and cocaine use in men and women with cocaine use disorder: A pilot trial. Drug And Alcohol Dependence 2025, 274: 112765. PMID: 40570771, PMCID: PMC12264926, DOI: 10.1016/j.drugalcdep.2025.112765.Peer-Reviewed Original ResearchCocaine use disorderCocaine useNeuroactive steroidsUse disorderTreatment of cocaine use disorderCocaine use outcomePregnenolone levelsTreatment-seeking individualsDays of cocaineChronic cocaine useExposure to stressPreg groupCocaine cuesCocaine cravingCraving responsesNeutral cuesInduce cravingCravingWeek 2CocaineChronic treatmentPilot findingsCocaine amountPrecursor pregnenoloneLinear mixed effects modelsNeuroendocrine responses and coupling to laboratory-induced stress in problem gambling and heavy smoking
Wemm S, Holzhauer C, Harrison L, Milivojevic V, Fogelman N, Cao Z, Wulfert E. Neuroendocrine responses and coupling to laboratory-induced stress in problem gambling and heavy smoking. Psychoneuroendocrinology 2025, 177: 107469. PMID: 40250213, PMCID: PMC12131328, DOI: 10.1016/j.psyneuen.2025.107469.Peer-Reviewed Original ResearchConceptsTrier Social Stress TestHypothalamic-pituitary-adrenal axisAxis responseProblem gamblingPathophysiology of addictive disordersHPA axis responseSocial Stress TestHypothalamic-pituitary-gonadal axisHealthy control participantsLaboratory-induced stressStress-related changesStress hormone cortisolHypothalamic-pituitary-gonadal axis hormonesAddictive disordersAddiction mechanismsLaboratory stressorSubstance addictionControl participantsNeuroactive steroidsNeuroendocrine responsesAttenuated cortisolPsychological featuresProblem gamblersHormone cortisolGamblingW139 Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study
Wemm S, Fogelman N, Sullivan L, Vacey E, Bera S, Hermes G, Swain J, Fox H, Sinha R. W139 Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study. Drug And Alcohol Dependence 2025, 267: 112081. DOI: 10.1016/j.drugalcdep.2024.112081.Peer-Reviewed Original ResearchM125 Guanfacine Improves Stroop Performance That in Turn Moderates Drug Treatment Effect on Cumulative Abstinence in Women With Polysubstance Use Disorder
Fogelman N, McGowan C, Wemm S, Tate M, Hermes G, Sinha R, Wemm S. M125 Guanfacine Improves Stroop Performance That in Turn Moderates Drug Treatment Effect on Cumulative Abstinence in Women With Polysubstance Use Disorder. Drug And Alcohol Dependence 2025, 267: 111719. DOI: 10.1016/j.drugalcdep.2024.111719.Peer-Reviewed Original Research